Challenges in the development of an efficient enzymatic process in the pharmaceutical industry
- 20 September 2004
- journal article
- review article
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 15 (18), 2757-2763
- https://doi.org/10.1016/j.tetasy.2004.07.050
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediatesProceedings of the National Academy of Sciences, 2004
- Creation of a Productive, Highly Enantioselective Nitrilase through Gene Site Saturation Mutagenesis (GSSM)Journal of the American Chemical Society, 2003
- A practical chemoenzymatic process to access (R)-quinuclidin-3-ol on scaleTetrahedron: Asymmetry, 2003
- Automated Enzyme Screening Methods for the Preparation of Enantiopure Pharmaceutical IntermediatesAdvanced Synthesis & Catalysis, 2003
- Enhancement of phase separation by the addition of de-emulsifiers to three-phase (diesel oil/biocatalyst/aqueous phase) emulsion in diesel biodesulfurizationBiotechnology Letters, 2003
- Process Design for Enzymatic Adipyl‐7‐ADCA HydrolysisBiotechnology Progress, 2002
- In‐situ product removal to enhance the yield of biocatalytic reactions with competing equilibria: α‐glucosidase catalysed synthesis of disaccharidesJournal of Chemical Technology & Biotechnology, 2001
- Lipase-catalyzed reaction in the packed-bed reactor with continuous extraction column to overcome a product inhibitionJournal of Molecular Catalysis B: Enzymatic, 2000
- Application of in situ product-removal techniques to biocatalytic processesTrends in Biotechnology, 1999
- Unprecedented Asymmetric Aldol Reactions with Three Aldehyde Substrates Catalyzed by 2-Deoxyribose-5-phosphate AldolaseJournal of the American Chemical Society, 1994